Alibaba Group and NetEase shares are showing technical signs of stabilization as Chinese equities attempt to bottom after a prolonged slump.
Source: https://www.barrons.com/articles/chinese-stocks-bottom-aliba…
Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie’s immunosuppressant portfolio helps it to produce steady revenue and profits.
Artificial intelligence (AI) offers a sky-high addressable market, which is something investors can appreciate. Nvidia’s and Palantir’s sustainable moats are what have made them so popular on Wall Street.
MU, LRCX and KLAC stand out as momentum stocks resurface, even as a tech rout and crypto slump rattle broader U.S. equity markets.
